查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1802938

VR 暴露療法市場預測（至 2032 年）：按組件、療法類型、技術、應用、最終用戶和地區進行的全球分析

VR Exposure Therapy Market Forecasts to 2032 - Global Analysis By Component, Therapy Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球 VR 暴露療法市場預計在 2025 年價值 4.0766 億美元，到 2032 年將達到 21.4849 億美元，預測期內的複合年成長率為 26.8%。

虛擬實境暴露療法 (VRET) 是一種心理療法，它利用身臨其境型虛擬環境，幫助患者在安全可控的環境中面對和管理恐懼、焦慮和創傷記憶。與依賴想像和真實生活情境的傳統暴露療法不同，VRET 允許治療師以高度的靈活性和真實感重現特定場景，例如飛行、公開演講或戰鬥環境。 VRET 對恐懼症、創傷後壓力症候群 (PTSD) 和社交焦慮等疾病尤其有效。

《虛擬實境前沿》（Frontiers in Virtual Reality）發表的一項研究發現，一次30分鐘的VR過度暴露療法就能顯著降低青少年的公開演講焦慮。參與者報告稱，他們的自信心和樂趣都有所提升，這證明了身臨其境型環境在治療社交焦慮症方面的潛力。

對非侵入性療法的需求日益成長

在全球範圍內，精神疾病的發生率不斷上升，推動了對創造性、非侵入性和有效治療方法的需求。 VR暴露療法透過提供安全、沉浸式的環境來滿足這項需求，患者可以在密切監督下逐漸面對自己的創傷和恐懼。與主要依賴想像力和有副作用的藥物的傳統談話療法相比，虛擬實境(VR)提供了一種積極的治療過程，並且療效可量化。 VR的互動性可以提高患者的參與度，尤其適合年輕人和不願嘗試傳統療法的人。

初始成本高且定價有限

軟體和設備的高昂初始成本是限制 VR 暴露療法市場的主要因素之一。先進的VR頭戴裝置、動作感測器和專門的治療軟體成本高昂，這給獨立治療師、小型診所和新興醫療系統採用這些療法帶來了困難。除了硬體之外，其他成本還包括系統維護、從業人員培訓和治療模組客製化。此外，許多保險公司仍然不願意承擔基於 VR 的干涉費用，因此只能由患者和醫療服務提供者自行承擔費用。儘管 VR 療法已被證明有效，但這些經濟差距減緩了它的普及，並限制了它的廣泛應用，尤其是在醫療預算有限的地區。

職場心理健康和企業健康的成長

VR暴露療法為企業健康計畫提供了巨大的潛力，尤其是在職場壓力、倦怠和焦慮日益加劇的當下。企業正在加大對員工心理健康專案的投入，以提高工作滿意度、員工留任率和工作效率。 VR解決方案可以幫助員工管理壓力、提高專注力，並克服公開演講等表現焦慮問題。這些解決方案可以遠端交付，也可以整合到企業健康中心。與傳統諮詢相比，遊戲化的虛擬實境療程可以提高健康項目的參與度。隨著企業轉向主動心理健康管理，虛擬實境療法提供了一種新穎且可擴展的解決方案，使服務提供者能夠利用盈利的企業醫療保健和人力資源市場。

來自替代醫學的競爭

儘管VR暴露療法具有獨特的優勢，但它仍面臨著來自新興和傳統數位解決方案的激烈競爭。由於成熟的報銷途徑和強力的臨床證據，藥物療法、認知行為療法 (CBT) 和傳統暴露療法仍然被廣泛使用。擴增實境療法、行動心理健康應用程式和人工智慧主導的認知介入等替代數位工具也越來越受歡迎。這些替代方案通常比VR更便宜、更容易獲得，並且所需的設備更少。此外，除非VR解決方案能夠以更好的療效和擴充性脫穎而出，否則其長期市場滲透率可能會受到限制。

COVID-19的影響：

新冠疫情 (COVID-19) 疫情對 VR 暴露療法市場造成了重大衝擊，既帶來了機遇，也帶來了挑戰。由於封鎖和保持社交距離措施限制了面對面的治療，對遠距和數位化心理健康解決方案（包括基於 VR 的干涉措施）的需求增加。隨著患者和臨床醫生轉向身臨其境型VR 平台，以便在家中安全地繼續進行暴露療法，遠端醫療整合 VR 解決方案的使用也隨之增加。同時，供應鏈中斷和硬體取得受限暫時限制了其應用。疫情凸顯了遠距、可擴展且技術先進的治療方法的重要性，使 VR 暴露療法成為現代心理健康護理的關鍵工具。

預計VR頭戴裝置市場將成為預測期內最大的市場

預計VR頭戴裝置領域將在預測期內佔據最大的市場佔有率。這些頭戴裝置對於提供3D身臨其境型治療體驗至關重要，使其成為治療焦慮症、恐懼症和創傷後壓力症候群 (PTSD) 的關鍵組成部分。由於虛擬實境技術的進步，獨立式、無線式和支援智慧型手機的頭戴裝置的開發提高了可近性和使用者舒適度。此外，由於 VR 暴露療法價格實惠且易於使用，該設備在臨床環境中的廣泛使用推動了其擴展。隨著對尖端心理健康治療的需求不斷成長， VR頭戴裝置預計將保持其市場領先地位。

預計遠端醫療平台和數位治療提供者部門將在預測期內實現最高的複合年成長率。

遠端醫療平台和數位療法提供者領域預計將在預測期內呈現最高成長率。對便捷的遠距心理健康介入服務的需求日益成長，尤其是在醫療資源匱乏和農村地區，這推動了這一成長。遠端醫療平台消除了等待時間和出行限制等障礙，使患者能夠在舒適的家中參與基於虛擬實境的暴露療法。數位療法提供者透過提供個人化、基於研究的治療內容，並頻繁整合人工智慧技術進行即時回饋和自適應治療方案，從而改善了這一體驗。

比最大的地區

預計北美將在預測期內佔據最大的市場佔有率，主要由加拿大和美國推動。該地區受益於對數位療法和心理健康研究的大量投資、數位健康技術的廣泛使用以及先進的醫療保健基礎設施。焦慮症、創傷後壓力症候群和恐懼症的盛行率不斷上升，以及人們對心理健康問題認知的不斷提高，正在加速診所、醫院和私人診所採用基於 VR 的暴露療法。此外，北美作為全球最盈利、成長最快的 VR 暴露療法市場的主導地位可以歸因於強力的政府舉措、優惠的報銷政策以及頂級 VR 技術提供者的存在。

複合年成長率最高的地區：

預計亞太地區 (APAC) 將在預測期內實現最高的複合年成長率。這一成長主要源於醫療保健的快速數位化、心理健康意識的不斷提升以及尖端治療技術的日益普及。中國、日本、印度和韓國等國家正在增加對基於虛擬實境 (VR) 的心理健康解決方案的投資，同時對遠端保健和醫療基礎設施的投資也在增加。此外，龐大的患者群體、日益成長的壓力和焦慮水平以及鼓勵數位醫療創新的政府計畫也推動了這個市場的發展。

提供免費客製化：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球VR暴露療法市場（按組件）

  • VR頭戴裝置
  • VR軟體和模組
  • VR工作站
  • VR耳機
  • VR位置追蹤器/感測器
  • 生物回饋療法監測器
  • 其他組件

6. 全球VR暴露療法市場（依治療類型）

  • 創傷後壓力症候群（PTSD）
  • 恐懼症
  • 焦慮症
  • 強迫性精神官能症（OCD）
  • 成癮和藥物濫用
  • 憂鬱症和情緒障礙
  • 其他治療類型

7. 全球VR暴露療法市場（按技術）

  • 完全身臨其境型現實
  • 半身臨其境型VR
  • 非身臨其境型VR
  • AI增強型VR
  • 觸覺整合虛擬實境

8. 全球VR暴露療法市場（按應用）

  • 管理精神障礙和成癮
  • 治療兒童焦慮和恐懼症
  • 教育和醫療培訓
  • 遠端醫療和遠端醫療整合
  • 其他用途

9. 全球VR暴露療法市場（按最終用戶）

  • 醫院和診所
  • 心理健康中心
  • 學術和研究機構
  • 私人治療實踐
  • 政府和國防機構
  • 遠端醫療平台和數位治療提供者
  • 其他最終用戶

第 10 章全球 VR 暴露療法市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Google
  • Accelerated Care Plus Corporation
  • Microsoft
  • ImmersiveTouch Inc
  • Oculus VR Inc
  • Atheer
  • Mindmaze Inc
  • BehaVR Inc
  • Limbix Inc.
  • AppliedVR Inc
  • Samsung Electronics
  • Virtually Better, Inc.
  • Echopixel Inc
  • XRHealth Inc
  • Truevision Inc
  • Vivid Vision
  • Oxford VR Inc
Product Code: SMRC30464

According to Stratistics MRC, the Global VR Exposure Therapy Market is accounted for $407.66 million in 2025 and is expected to reach $2148.49 million by 2032 growing at a CAGR of 26.8% during the forecast period. Virtual Reality Exposure Therapy (VRET) is a type of psychological treatment that helps people face and control their fears, anxieties, or traumatic memories in a safe and controlled environment by using immersive virtual environments. In contrast to conventional exposure therapy, which depends on imagination or real-world circumstances, VRET enables therapists to replicate particular scenarios-like flying, public speaking, or combat environments-with a high level of flexibility and realism. It is particularly useful for disorders like phobias, post-traumatic stress disorder (PTSD), and social anxiety because it allows patients to gradually become less sensitive to their triggers while still feeling safe.

According to a study published in Frontiers in Virtual Reality, a single 30-minute session of VR-based overexposure therapy significantly reduced public speaking anxiety among adolescents. Participants reported improved confidence and enjoyment, demonstrating the potential of immersive environments to treat social anxiety disorders.

Market Dynamics:

Driver:

Growing need for engaging, non-invasive therapies

Globally, the prevalence of mental health disorders is rising, which has increased demand for creative, non-invasive, and effective treatment approaches. This need is met by VR exposure therapy, which provides safe, immersive settings in which patients can progressively face traumas or fears while being closely monitored. Virtual reality (VR) offers an active therapeutic process with quantifiable progress, in contrast to traditional talk therapy that mainly relies on imagination or medications that may have negative side effects. It is particularly useful for younger populations or those who are hesitant to try conventional therapy because of its interactive nature, which guarantees higher patient engagement.

Restraint:

Expensive initial outlay and restricted affordability

The high initial cost of software and equipment is one of the main factors limiting the market for VR exposure therapy. Adoption is challenging for independent therapists, small clinics, and emerging healthcare systems due to the high cost of advanced VR headsets, motion sensors, and specialized therapeutic software. In addition to hardware, other expenses include maintaining systems, training practitioners, and customizing therapy modules. Moreover, the cost of VR-based interventions is still borne by patients or providers because many insurers are still reluctant to pay for them. Even though VR therapy has been shown to be effective, its democratization is being slowed down by this affordability gap, which restricts its widespread adoption, particularly in areas with low healthcare budgets.

Opportunity:

Growth in workplace mental health and corporate wellness

VR exposure therapy has a lot of potential for corporate wellness programs, especially since workplace stress, burnout, and anxiety are on the rise. Businesses are spending more money on employee mental health programs in an effort to increase job satisfaction, retention, and productivity. VR solutions can help employees manage stress, increase focus, and get over performance anxiety issues like public speaking. They can be offered remotely or integrated into corporate wellness centers. Compared to traditional counseling, gamified virtual reality sessions enhance the engagement of wellness programs. As businesses move toward proactive mental health management, virtual reality therapy presents a novel, scalable solution that puts providers in a position to take advantage of the profitable corporate healthcare and human resources markets.

Threat:

Competition from alternative medical practices

Even though VR exposure therapy has special advantages, it is fiercely competitive with both new and traditional digital solutions. Medication, cognitive behavioral therapy (CBT), and traditional exposure therapy are still commonly used because they have established reimbursement pathways and strong clinical evidence. Alternative digital tools are also becoming more popular, including augmented reality therapies, mobile mental health apps, and AI-driven cognitive interventions. Comparing these alternatives to VR, they are frequently less expensive, more accessible, and require less equipment. Additionally, long-term market penetration may be limited if VR solutions are unable to set themselves apart with better results and scalability, as they run the risk of losing market share to these rival therapeutic modalities.

Covid-19 Impact:

The market for VR exposure therapy was significantly impacted by the COVID-19 pandemic, which presented both opportunities and difficulties. Demand for remote and digital mental health solutions, such as VR-based interventions, increased as a result of lockdowns and social distancing measures that limited in-person therapy sessions. The use of telehealth-integrated VR solutions has increased as patients and clinicians have resorted to immersive VR platforms to safely continue exposure therapy from home. At the same time, deployment was momentarily limited by supply chain interruptions and restricted hardware access. All things considered, the pandemic demonstrated the importance of remote, scalable, and technologically advanced therapeutic approaches, establishing VR exposure therapy as a vital instrument in contemporary mental health care.

The VR headset segment is expected to be the largest during the forecast period

The VR headset segment is expected to account for the largest market share during the forecast period. These headsets are essential for providing three-dimensional, immersive therapeutic experiences, which makes them a key component of treatments for anxiety disorders, phobias, and PTSD. The development of standalone, wireless, and smartphone-compatible headsets has improved accessibility and user comfort as a result of advancements in virtual reality technology. Moreover, the expansion of VR exposure therapy has been fueled by the devices' widespread use in clinical settings, which can be attributed to their affordability and ease of use. VR headsets are anticipated to maintain their market-leading position as the need for cutting-edge mental health treatments increases.

The telehealth platforms & digital therapeutics providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the telehealth platforms & digital therapeutics providers segment is predicted to witness the highest growth rate. The growing need for easily accessible, remote mental health interventions-particularly in underprivileged or rural areas-is what is driving this expansion. By removing obstacles like wait times and travel restrictions, telehealth platforms allow patients to participate in VR-based exposure therapy from the convenience of their homes. By providing individualized, research-based therapeutic content and frequently incorporating AI for real-time feedback and adaptive treatment plans, digital therapeutics providers improve these experiences.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, primarily propelled by Canada and the United States. The area gains from substantial investments in digital therapeutics and mental health research, as well as from the extensive use of digital health technologies and sophisticated healthcare infrastructure. The growing prevalence of anxiety, PTSD, and phobias, along with increased awareness of mental health issues, has sped up the adoption of VR-based exposure therapy in clinics, hospitals, and private therapy settings. Furthermore, North America's dominant position as the most profitable and quickly developing market for VR exposure therapy worldwide is a result of robust government initiatives, advantageous reimbursement policies, and the presence of top VR technology providers.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific (APAC) region is anticipated to exhibit the highest CAGR. This expansion is being propelled by the quick digitization of healthcare, rising mental health awareness, and expanding use of cutting-edge therapeutic technologies. Growing investments in VR-based mental health solutions are being seen in nations like China, Japan, India, and South Korea, as well as in telehealth and healthcare infrastructure. Furthermore, the market is expanding due to a sizable patient base, increased stress and anxiety levels, and government programs that encourage innovation in digital health.

Key players in the market

Some of the key players in VR Exposure Therapy Market include Google, Accelerated Care Plus Corporation, Microsoft, ImmersiveTouch Inc, Oculus VR Inc, Atheer, Mindmaze Inc, BehaVR Inc, Limbix Inc., AppliedVR Inc, Samsung Electronics, Virtually Better, Inc., Echopixel Inc, XRHealth Inc, Truevision Inc, Vivid Vision and Oxford VR Inc.

Key Developments:

In February 2025, Microsoft Corp. and Anduril Industries announced an expanded partnership to drive the next phase of the U.S. Army's Integrated Visual Augmentation System (IVAS) program. Through this partnership agreement, and pending Department of Defense approval, Anduril will assume oversight of production, future development of hardware and software, and delivery timelines.

In February 2025, XRHealth and extended reality (XR) solutions, announces that they acquired the immersive, digital therapeutics company RealizedCare, further advancing AI-powered, value-based care in healthcare. With this acquisition, XRHealth solidifies its position as the largest AI-driven therapeutic XR platform worldwide.

In December 2024, Google is teaming up with Samsung to take on Meta and Apple in the resurgent market for smart glasses and virtual-reality headsets, almost a decade after suspending consumer sales of its controversial Google Glass device. Samsung will release the first device based on a new version of Google's Android smartphone operating system that has been customised for headsets and glasses, which the Alphabet-owned internet group described as the next generation of computing.

Components Covered:

  • VR Headset
  • VR Software & Modules
  • VR Workstation
  • VR Earphones
  • VR Position Tracker/ Sensors
  • Biofeedback Monitor
  • Other Components

Therapy Types Covered:

  • Post-Traumatic Stress Disorder (PTSD)
  • Phobias
  • Anxiety Disorders
  • Obsessive-Compulsive Disorder (OCD)
  • Addiction & Substance Abuse
  • Depression & Mood Disorders
  • Other Therapy Types

Technologies Covered:

  • Fully Immersive VR
  • Semi-Immersive VR
  • Non-Immersive VR
  • AI-Enhanced VR
  • Haptic-Integrated VR

Applications Covered:

  • Mental Disorder & Addiction Management
  • Pediatric Anxiety & Phobia Treatment
  • Education & Medical Training
  • Remote Therapy & Telehealth Integration
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Mental Health Centers
  • Academic & Research Institutions
  • Private Therapy Practices
  • Government & Defense Organizations
  • Telehealth Platforms & Digital Therapeutics Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global VR Exposure Therapy Market, By Component

  • 5.1 Introduction
  • 5.2 VR Headset
  • 5.3 VR Software & Modules
  • 5.4 VR Workstation
  • 5.5 VR Earphones
  • 5.6 VR Position Tracker/ Sensors
  • 5.7 Biofeedback Monitor
  • 5.8 Other Components

6 Global VR Exposure Therapy Market, By Therapy Type

  • 6.1 Introduction
  • 6.2 Post-Traumatic Stress Disorder (PTSD)
  • 6.3 Phobias
  • 6.4 Anxiety Disorders
  • 6.5 Obsessive-Compulsive Disorder (OCD)
  • 6.6 Addiction & Substance Abuse
  • 6.7 Depression & Mood Disorders
  • 6.8 Other Therapy Types

7 Global VR Exposure Therapy Market, By Technology

  • 7.1 Introduction
  • 7.2 Fully Immersive VR
  • 7.3 Semi-Immersive VR
  • 7.4 Non-Immersive VR
  • 7.5 AI-Enhanced VR
  • 7.6 Haptic-Integrated VR

8 Global VR Exposure Therapy Market, By Application

  • 8.1 Introduction
  • 8.2 Mental Disorder & Addiction Management
  • 8.3 Pediatric Anxiety & Phobia Treatment
  • 8.4 Education & Medical Training
  • 8.5 Remote Therapy & Telehealth Integration
  • 8.6 Other Applications

9 Global VR Exposure Therapy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Mental Health Centers
  • 9.4 Academic & Research Institutions
  • 9.5 Private Therapy Practices
  • 9.6 Government & Defense Organizations
  • 9.7 Telehealth Platforms & Digital Therapeutics Providers
  • 9.8 Other End Users

10 Global VR Exposure Therapy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Google
  • 12.2 Accelerated Care Plus Corporation
  • 12.3 Microsoft
  • 12.4 ImmersiveTouch Inc
  • 12.5 Oculus VR Inc
  • 12.6 Atheer
  • 12.7 Mindmaze Inc
  • 12.8 BehaVR Inc
  • 12.9 Limbix Inc.
  • 12.10 AppliedVR Inc
  • 12.11 Samsung Electronics
  • 12.12 Virtually Better, Inc.
  • 12.13 Echopixel Inc
  • 12.14 XRHealth Inc
  • 12.15 Truevision Inc
  • 12.16 Vivid Vision
  • 12.17 Oxford VR Inc

List of Tables

  • Table 1 Global VR Exposure Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global VR Exposure Therapy Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global VR Exposure Therapy Market Outlook, By VR Headset (2024-2032) ($MN)
  • Table 4 Global VR Exposure Therapy Market Outlook, By VR Software & Modules (2024-2032) ($MN)
  • Table 5 Global VR Exposure Therapy Market Outlook, By VR Workstation (2024-2032) ($MN)
  • Table 6 Global VR Exposure Therapy Market Outlook, By VR Earphones (2024-2032) ($MN)
  • Table 7 Global VR Exposure Therapy Market Outlook, By VR Position Tracker/ Sensors (2024-2032) ($MN)
  • Table 8 Global VR Exposure Therapy Market Outlook, By Biofeedback Monitor (2024-2032) ($MN)
  • Table 9 Global VR Exposure Therapy Market Outlook, By Other Components (2024-2032) ($MN)
  • Table 10 Global VR Exposure Therapy Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 11 Global VR Exposure Therapy Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2024-2032) ($MN)
  • Table 12 Global VR Exposure Therapy Market Outlook, By Phobias (2024-2032) ($MN)
  • Table 13 Global VR Exposure Therapy Market Outlook, By Anxiety Disorders (2024-2032) ($MN)
  • Table 14 Global VR Exposure Therapy Market Outlook, By Obsessive-Compulsive Disorder (OCD) (2024-2032) ($MN)
  • Table 15 Global VR Exposure Therapy Market Outlook, By Addiction & Substance Abuse (2024-2032) ($MN)
  • Table 16 Global VR Exposure Therapy Market Outlook, By Depression & Mood Disorders (2024-2032) ($MN)
  • Table 17 Global VR Exposure Therapy Market Outlook, By Other Therapy Types (2024-2032) ($MN)
  • Table 18 Global VR Exposure Therapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global VR Exposure Therapy Market Outlook, By Fully Immersive VR (2024-2032) ($MN)
  • Table 20 Global VR Exposure Therapy Market Outlook, By Semi-Immersive VR (2024-2032) ($MN)
  • Table 21 Global VR Exposure Therapy Market Outlook, By Non-Immersive VR (2024-2032) ($MN)
  • Table 22 Global VR Exposure Therapy Market Outlook, By AI-Enhanced VR (2024-2032) ($MN)
  • Table 23 Global VR Exposure Therapy Market Outlook, By Haptic-Integrated VR (2024-2032) ($MN)
  • Table 24 Global VR Exposure Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global VR Exposure Therapy Market Outlook, By Mental Disorder & Addiction Management (2024-2032) ($MN)
  • Table 26 Global VR Exposure Therapy Market Outlook, By Pediatric Anxiety & Phobia Treatment (2024-2032) ($MN)
  • Table 27 Global VR Exposure Therapy Market Outlook, By Education & Medical Training (2024-2032) ($MN)
  • Table 28 Global VR Exposure Therapy Market Outlook, By Remote Therapy & Telehealth Integration (2024-2032) ($MN)
  • Table 29 Global VR Exposure Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 30 Global VR Exposure Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global VR Exposure Therapy Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 32 Global VR Exposure Therapy Market Outlook, By Mental Health Centers (2024-2032) ($MN)
  • Table 33 Global VR Exposure Therapy Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
  • Table 34 Global VR Exposure Therapy Market Outlook, By Private Therapy Practices (2024-2032) ($MN)
  • Table 35 Global VR Exposure Therapy Market Outlook, By Government & Defense Organizations (2024-2032) ($MN)
  • Table 36 Global VR Exposure Therapy Market Outlook, By Telehealth Platforms & Digital Therapeutics Providers (2024-2032) ($MN)
  • Table 37 Global VR Exposure Therapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.